EWA
BLFS

EverSource Wealth Advisors’s BioLife Solutions BLFS Stock Holding History

EverSource Wealth Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480 Buy
17
+2
+13% +$47 ﹤0.01% 4138
2026
Q1 		$286 Buy
+15
New +$332 ﹤0.01% 4157
2025
Q2 		– Sell
-1
Closed -$23 – 4263
2025
Q1 		$23 Sell
1
-25
-96% -$658 ﹤0.01% 3961
2024
Q4 		$675 Buy
+26
New +$647 ﹤0.01% 3093

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EverSource Wealth Advisors's BLFS Position: Q2 2026 in Review

EverSource Wealth Advisors increased its BioLife Solutions (BLFS) stake by 13% in Q2 2026, buying an estimated $47 and bringing the position to 17 shares worth $480. The position accounts for ﹤0.01% of the portfolio, ranked #4138.

EverSource Wealth Advisors first reported a position in BLFS in Q4 2024 and has held it in 4 quarters since. The position peaked at $675 in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • EverSource Wealth Advisors held 17 shares of BioLife Solutions worth $480 as of Q2 2026.
  • EverSource Wealth Advisors bought 2 BioLife Solutions shares in Q2 2026, an estimated $47.
  • BioLife Solutions made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4138 holding.
  • EverSource Wealth Advisors first reported a position in BioLife Solutions in Q4 2024 and has held it in 4 quarters since.
  • EverSource Wealth Advisors's BioLife Solutions position peaked at $675 in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.